Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Acurx Pharmaceuticals, Inc.ACXP · Entity 8195 | Director | April 20, 2026 | April 22, 2026 |
| OptiNose, Inc.OPTN · Entity 79464 | Director | June 08, 2022 | June 09, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Acurx Pharmaceuticals, Inc.
Report date April 20, 2026 · Filed April 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $2.36 · Expires 2036-04-20 | Direct | 2,150 |
Reported balance
After 2026-04-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-20 · Grant · Acquired 2,150 · Balance 2,150 F1: This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on April 20, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on April 20, 2027.
OptiNose, Inc.
Report date June 08, 2022 · Filed June 09, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.95 · Expires 2032-06-08 | Direct | 32,000 |
Reported balance
After 2022-06-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-08 · Grant · Acquired 32,000 · Balance 32,000 F1: The option vests and becomes exercisable on the earlier of (i) June 8, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests and becomes exercisable on the earlier of (i) June 8, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
JOHNSON & JOHNSON
Report date May 28, 2008 · Filed May 30, 2008
Section 16 reporting ended · disclosed 2008-05-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 18,646 |
Reported balance
After 2008-05-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2008-05-28 · Exercise / conversion · Acquired 2,100 · Balance 18,646 F1: Adjusted to reflect two-for-one stock split in 2001. F2: Includes 170 shares held under Issuer's Dividend Reinvestment Plan. |
| CommonSEC Table I · non-derivative | Direct | 83,731 |
Reported balance
After 2008-05-28 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2008-05-28 · Exercise / conversion · Acquired 65,085 · Balance 83,731 |
| CommonSEC Table I · non-derivative | Direct | 75,982 |
Reported balance
After 2008-05-28 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2008-05-28 · Sale · Disposed 7,749 · Balance 75,982 |
| CommonSEC Table I · non-derivative | Direct | 49,056 |
Reported balance
After 2008-05-28 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2008-05-28 · Sale · Disposed 26,926 · Balance 49,056 |
| CommonSEC Table I · non-derivative | Direct | 23,171 |
Reported balance
After 2008-05-28 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2008-05-28 · Sale · Disposed 25,885 · Balance 23,171 |
| CommonSEC Table I · non-derivative | Direct | 22,746 |
Reported balance
After 2008-05-28 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2008-05-28 · Sale · Disposed 425 · Balance 22,746 |
| CommonSEC Table I · non-derivative | Direct | 18,646 |
Reported balance
After 2008-05-28 transaction · row 7
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 7 · 2008-05-28 · Sale · Disposed 4,100 · Balance 18,646 |
| CommonSEC Table I · non-derivative | Indirect401 (k) and ESOP Savings Plans | 2,845 |
Reported balance
After 2008-04-30 transaction · row 8
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 8 · 2008-04-30 · Other · Acquired 98 · Balance 2,845 F3: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (4/30/2008). |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.39 · Expires 2009-10-06 | Direct | 0 |
Reported balance
After 2008-05-28 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2008-05-28 · Exercise / conversion · Disposed 2,100 · Balance 0 F4: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. F1: Adjusted to reflect two-for-one stock split in 2001. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $52.20 · Expires 2011-03-20 | Direct | 0 |
Reported balance
After 2008-05-28 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2008-05-28 · Exercise / conversion · Disposed 65,085 · Balance 0 F4: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Adjusted to reflect two-for-one stock split in 2001.
F2: Includes 170 shares held under Issuer's Dividend Reinvestment Plan.
F3: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (4/30/2008).
F4: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 24, 2006 Filed Oct 26, 2006 15:19 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon | 58,000 | $50.69 | $2,940,020.00 |
DisclosureSEC source: 0000200406-06-000136 · edgar.xml · nonDerivative · entry 1 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Adjusted to reflect two-for-one stock split in 2001. Read SEC document |
| September 30, 2006 Filed Oct 26, 2006 15:19 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 140 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-06-000136 · edgar.xml · nonDerivative · entry 9 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (k) and ESOP Savings Plans Disclosed balance after: 2,501 F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (09/29/2006). Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 20:35 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantCommon | 1,538 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-06-000053 · edgar.xml · nonDerivative · entry 1 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,928 F1 · price: Awarded under Issuer's Executive Incentive Plan. Read SEC document |
| February 13, 2006 Filed Feb 15, 2006 17:13 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 7,713 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-06-000034 · edgar.xml · derivative · entry 4 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,713 Underlying: Common Stock · 7,713 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one share of Company common stock. F4 · derivative.expiration_date: The restricted share units vest three years after date of grant. Read SEC document |
| February 13, 2006 Filed Feb 15, 2006 17:13 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Option (Right to Buy) · Derivative | 92,561 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0000200406-06-000034 · edgar.xml · derivative · entry 3 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,561 Underlying: Common Stock · 92,561 shares Expires 2016-02-12 F2 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| January 31, 2006 Filed Feb 15, 2006 17:13 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 122 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-06-000034 · edgar.xml · nonDerivative · entry 2 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (k) and ESOP Savings Plans Disclosed balance after: 2,361 F1 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (01/31/2006). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.